肺癌中的外体LncRNAs和CircRNAs:新兴的调节剂和潜在的治疗点
Xia Li1, Yunbing Wu2, Yue Jin1
1Center of Molecular Diagnostic, Northern Jiangsu People's Hospital of Jiangsu Province, Yangzhou, 225001, China.
Non-coding RNA research
|July 18, 2024
概括
外基因组携带非编码RNA (ncRNA),如长非编码RNA (lncRNA) 和圆形RNA (circRNA),对于肺癌的进展至关重要. 这些外体的ncRNAs显示为改善肺癌管理的诊断和预后生物标志物具有前途.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 肺癌是全球癌症死亡的主要原因,通常在晚期被诊断出来,需要新的生物标志物来改善结果.
- 外体细胞促进细胞间通信,并与肺癌的进展有关.
- 非编码RNAs (ncRNAs),包括长非编码RNAs (lncRNAs) 和圆形RNAs (circRNAs),在外体中丰富,并调节细胞过程.
研究的目的:
- 在肺癌中审查外体lncRNAs和circRNAs的形成和生物学作用.
- 阐明这些分子驱动肺癌进展的机制.
- 讨论外体ncRNAs作为生物标志物和治疗点的临床潜力和挑战.
主要方法:
- 文献综述侧重于外体生物发生和ncRNA内容.
- 对详细介绍肺癌中外体lncRNAs和circRNAs功能的研究进行分析.
- 综合关于临床应用和未来方向的信息.
主要成果:
- 外体lncRNAs和circRNAs是肺癌细胞间通信的关键媒介.
- 这些ncRNAs影响关键的癌症特征,如上皮细胞-介质细胞过渡 (EMT),血管生成,增殖,入侵,迁移和转移.
- 外体ncRNA显示出作为肺癌诊断和预后的敏感生物标志物的潜力.
结论:
- 外体lncRNAs和circRNAs在肺癌的发病和进展中起着重要的作用.
- 它们在关键癌症过程中的参与凸显了它们作为治疗点的潜力.
- 需要进一步的研究来克服挑战,并将这些发现转化为肺癌管理的临床应用.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
03:18Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K
01:22MicroRNAs
21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K